News Releases

SUBMENUarrowSubmit RFP/RFIarrow

News Releases

Date 2019 News Releases —View Less
10/15/19 Synteract Presents Webinar on Integrated Summaries: Planning for the Unexpected & Reacting to the Unforeseen
09/27/19 Synteract Presents and Participates in Industry Conferences to Continue Engaging on Key Clinical Development Topics
09/26/19 Synteract Presents Webinar on The Increasing Role of Pharmacometrics in Drug Development
09/25/19 Synteract Augments Leadership Team for Oncology and Rare Disease Centers of Development
09/17/19 Synteract Presents Webinar: Utilizing Inventive Biostatistical Methods to Enhance Rare Disease Trials
09/12/19 Synteract Adds General Medicine Center of Development to Meet Market Demand and Further Align with Its Longstanding Experience
09/12/19 Synteract Names Dr. Art Wamil to Lead Neuroscience Center of Development
08/29/19 Synteract Thought Leaders to Address Industry Trends at Upcoming Conferences
08/01/19 Synteract’s Lisa Dilworth Named To PharmaVOICE 100 — The Most Inspiring People in Life Sciences
05/29/19 Global Experts Hit the Road to Address Complexities in Navigating Clinical Trials
05/20/19 Global Experts to Address Navigating Pediatric Drug Development Regulations in the U.S. and EU in Synteract Webinar
04/30/19 Synteract Bolsters its Oncology, Neuro Degenerative and Rare Disease Centers of Development with Two New Executives
04/18/19 Webinar Presentation: A Closer Look at Working with Caregivers in Clinical Trials, Especially in Cases of Rare Diseases
03/20/19 Synteract’s Continued Growth as a Leading CRO Results in Plans to Open Additional Office in Swansea, Wales
03/07/19 Synteract Experts To Address Challenges In Rare and Orphan Diseases at WODC US and Patients As Partners Conferences
02/28/19 Synteract To Showcase Dermatologic Center of Development at American Academy of Dermatology Annual Meeting
02/11/19 Synteract Announces Participation in February/March Industry Events
Date 2018 News Releases —View Less
11/15/18 Synteract Acquires Pediatric CRO KinderPharm to Further Strengthen its Pediatric Center of Development
10/22/18 Synteract’s Head of Pediatric Development to Present at Better Medicines for Children Conference, Belgium
09/25/18 Synteract Adds to Leadership Team with Rare and Orphan Disease Experts Lisa Dilworth and Elisabeth Schrader
08/01/18 Synteract’s Francoise Desir Named To The 2018 PharmaVOICE 100
07/19/18 Synteract Augment Executive Team Appointing Cheryl Murphy
07/11/18 Synteract Acquires Dermatology Specialist CRO Cu-Tech, Adding Center of Development in Dermatology
06/25/18 Synteract Announces Collaboration with International Children’s Advisory Network iCAN Research
06/20/18 Synteract Exhibiting and Introducing Leaders for Therapeutic Development at DIA 2018 in Boston
04/19/18 Synteract Repositions Itself with Centers of Therapeutic Development and Unveils Updated Brand Platform
03/21/18 Synteract Adds Mary Mattes as Senior Vice President Biometrics and Drug Safety
01/30/18 Synteract Appoints Jack Shannon As New Chief Commercial Officer
01/17/18 Synteract Adds Karl Deonanan as Chief Financial Officer to Take Company Into Next Phase of Growth
Date 2017 News Releases —View Less
11/20/17 Synteract Thought Leaders to Speak & Exhibit at Partnerships in Clinical Trials Europe in Amsterdam
10/25/17 CRO Industry Veteran John Potthoff Joins Synteract Board of Directors
10/03/17 Synteract Moves to New Headquarters in Carlsbad, San Diego County, California
08/09/17 Synteract Announces New Chief Medical Officer Dr. Frank Santoro
07/31/17 Synteract CEO Steve Powell and Vice President Etienne Drouet Named to PharmaVOICE 100’s Most Inspiring People in Life Sciences
07/16/17 Synteract Names Steve Powell as Chief Executive Officer
05/30/17 Synteract Executives Emphasize Clinical Research Expertise by Presenting and Attending June Conferences
04/18/17 Synteract Adds Another Three Senior Executives To Management Team With Both U.S. and International Clinical Trials Operations Experience
04/11/17 Synteract Continues to Show International Clinical Trial Expertise by Participating in European Conferences This Spring
01/31/17 Synteract Experts Slated to Speak at Leading Drug Development Conferences
01/03/17 Synteract Expands With Four New Experts Added To Global Leadership Team
Date 2016 News Releases —View Less
12/06/16 Dr. Martine Dehlinger-Kremer of Synteract Elected President of European CRO Federation, EUCROF
11/09/16 Synteract Continues Its Conference and Speaking Engagements in November
11/08/16 Dr. Martine Dehlinger-Kremer of Synteract Nominated Chair of Children’s Medicines Working Party for European Forum for Good Clinical Practice
10/09/16 Synteract Expands Its Conference Speaking Engagements in October
10/04/16 Synteract Continues to Bolster Senior Leadership Ranks to Match Global Growth
08/31/16 Synteract Proves Industry Expertise Through Conference and Webinar Education
06/13/16 Synteract Presenting and Exhibiting at DIA 2016 Annual Meeting in Philadelphia
05/24/16 Synteract Acquired by Equity Investment Group Amulet Capital Partners, LP.
05/09/16 Synteract Honored with Five Life Science Leader 2016 CRO Leadership Awards
05/03/16 Synteract Experts Continue Presentations at U.S. and European Events Focused on Outsourcing in Clinical Trials
04/19/16 Synteract Becomes Oracle PartnerNetwork Gold Level Partner
04/11/16 Synteract Global Medical and Regulatory Affairs Expert, Dr. Martine Dehlinger-Kremer, Speaking at Nordic ePharma Day and Pediatric Drug Development Conferences in April
03/29/16 Synteract Team Participates in San Diego "Fight for Air" Climb Sponsored by the American Lung Association
03/13/16 Synteract Increases Presence in East Coast Biotech Markets Through Presentations at OCT Southeast and Clinical Trial Collaborations Conferences
02/03/16 Synteract Begins 2016 at U.S. and European Events Focused on Improving Clinical Trial Processes
01/11/16 Synteract Becomes Accredited in Medidata Balance to Broaden Randomization and Trial Supply Management Capabilities
Date 2015 News Releases —View Less
11/09/15 Synteract to Share Insights on the New EU Clinical Trials Regulation at 2015 Partnerships in Clinical Trials Europe
10/26/15 Synteract Appoints Vice President of Global Clinical Operations
09/09/15 Synteract Experts Sharing Insights on Drug Development Topics at US and European Biopharma Events During Fall 2015
09/02/15 Synteract Enhances Technology Offerings for Clients through Upgrades, Certifications and Additions
08/11/15 Synteract Requalifies as Certified Member of BVMA, the Federal Association of CROs in Germany
08/03/15 Synteract Vice President, Global Medical and Regulatory Affairs, Dr. Martine Dehlinger-Kremer Named One of PharmaVOICE 100’s Most Inspiring People in Life Sciences
06/22/15 Synteract to Share Insights on Clinical Trials in Orphan Indications at Outsourcing in Clinical Trials UK & Ireland 2015
05/10/15 Synteract Honored with Four Life Science Leader 2015 CRO Leadership Awards
05/06/15 Synteract Presents and Exhibits at European and US Biopharma and Life Sciences Events during Spring 2015
04/21/15 Synteract Announces Webinar Series for Clinical Research and Biopharma Professionals
03/11/15 Synteract Exhibiting and Presenting on Electronic Data Capture at Outsourcing in Clinical Trials Southeast Conference
02/25/15 Synteract Expands Senior Management Team with Appointment of Etienne Drouet as Vice President, Strategic Development
01/26/15 Synteract’s Senior Leadership to Participate in International and Domestic Clinical Trials Conferences
01/21/15 Synteract Hosting CDISC Training Classes in Southern California and North Carolina on Regulatory Data Standards
01/13/15 Synteract Expands Senior Leadership to Oversee Growth of International Projects
Date 2014 News Releases —View Less
11/13/14 Dr. Martine Dehlinger-Kremer, Global Vice President Medical and Regulatory Affairs for Synteract, to Speak on Pediatric Research at Pharmig/OKIDS Conference in Vienna
10/28/14 Synteract Joins the International Biopharma Community at the Thirteenth Annual Partnerships in Clinical Trials Congress in Europe
09/09/14 Synteract Presenting and Exhibiting at Three Biopharma and Life Sciences Events This Fall
08/03/14 Synteract Chief Medical Advisor Dr. Stephan de la Motte Named One of the PharmaVOICE 100 Most Inspiring People in Life Sciences
07/15/14 ECCRT, a Synteract Company, Continues to Garner Recognition and Partners for Clinical Trials Training Courses
06/03/14 Synteract Presenting and Exhibiting at DIA 2014 50th Annual Meeting
05/05/14 Synteract Experts Speaking at Outsourcing in Clinical Trials U.S. and European Shows
04/21/14 Synteract Appoints Martine Dehlinger-Kremer, Ph.D., as Vice President, Global Medical and Regulatory Affairs
04/07/14 ECCRT, a Synteract Company, Recognized as an Accredited Training Facility by TransCelerate BioPharma Inc.
Date 2013 News Releases —View Less
11/11/13 Synteract Supports the San Diego Rescue Mission for Second Year in a Row
10/16/13 Synteract Participates in “Making Strides Against Breast Cancer” Fundraising Walk to Support the American Cancer Society
10/06/13 Synteract Expands Participation in Industry Events across Three Continents
09/10/13 Synteract Promotes Education to Take Time and Cost out of Drug Development with ICD+ Webinar Series
08/19/13 Synteract Increasing Participation in Industry Events in US and Europe
07/31/13 Synteract Senior Director of Clinical Operations Mary Clegg Named One of the PharmaVOICE 100 Most Inspiring People in Life Sciences
07/14/13 Synteract Posts Regulatory Updates to Help Biopharma Clients Stay Current on International Regulations
06/12/13 Synteract Launches Intelligent Clinical Development Platform at DIA 2013 to Support Trial Efficiencies Globally
05/29/13 Synteract Enhances Adaptive Trial Capabilities
05/20/13 Synteract Expands Participation in Industry Meetings in US and Europe
05/01/13 Synteract Addressing Successful Ways to Approach Sponsor and CRO Collaboration at May Pharmaceutical Events in US and Europe
04/04/13 Synteract Participating in New Orleans BioInnovation Center Event
04/01/13 Synteract Appoints Bill Pierce as Chief Information Officer and Richard Paul as Chief Medical Officer and Vice President Medical/Regulatory Affairs
02/28/13 Synteract and Harrison Clinical Research Close Deal to Form Multinational CRO
01/29/13 Synteract Appoints Keith Kelson as Chief Financial Officer and Member of Executive Council and Philip Doren, Ph.D., as Vice President, Biometrics
Date 2012 News Releases —View Less
12/20/12 Synteract Participating in January Pharmaceutical Industry Events on the West Coast
12/18/12 Synteract on Acquiring Multinational CRO Harrison Clinical Research
10/24/12 Synteract Upgrades Safety Database Systems to Oracle Argus
09/12/12 Synteract Leaders to Attend West & East Coasts Industry Events
08/01/12 Senior Director Olivia Montaño Honored as One of the PharmaVOICE 100
07/23/12 Synteract to Host Joint Statistical Meeting Roundtable in San Diego
06/11/12 Synteract Unveils New Branding at DIA 2012
05/08/12 Synteract Sponsored & Presented at Outsourcing in Clinical Trials
05/01/12 Synteract & Rempex Partner in “Great Strides” Walk
03/18/12 Synteract Director of IT Services Toby Odenheim Speaking at March 2012 Outsourcing in Clinical Trials East Coast Conference
03/04/12 Synteract Expands Executive Roles to Support Growth
02/16/12 Synteract Hosted CDISC Classes on Regulatory Data Standards
01/30/12 Synteract Releases SynCapture Version 1.5 of its Hybrid Electronic Data Capture (EDC) System
Date 2011 News Releases —View Less
12/06/11 Synteract Becomes First Medidata Service Partner Accredited in Rave Safety Gateway
11/09/11 Synteract and MediciNova Partner in “Fight For Air Walk” to Support the American Lung Association in California
09/13/11 Synteract Senior Director Kristi Clark to Present on Effective Communication Plans for Vendor Management at Outsourcing in Clinical Trials New England Conference
09/05/11 Synteract Makes Inc. Magazine’s Fifth Annual Exclusive List of America’s Fastest-Growing Private Companies, the Inc. 5000
07/17/11 Wendel Barr Joins Synteract as Chief Executive
06/16/11 Synteract Achieves Study Build Accreditation In Medidata Solutions Channel Partner Program
05/17/11 Synteract and Mpex Pharmaceuticals Team Up for Cystic Fibrosis Walk and Cure
03/01/11 Ellen Morgan Becomes Chairman of the Board at Synteract
02/16/11 Synteract Achieves Rave Accreditation in Medidata’s ASPire to Win Channel Program
Date 2010 News Releases —View Less
12/19/10 Synteract CEO Ellen Morgan Awarded Most Admired CEO of the Year Honors
10/31/10 Synteract Triples Space in NC Office to Accommodate Growth
06/08/10 Synteract Joins Medidata Solutions’ Growing Roster of ASPire to Win Channel Partners
05/24/10 Synteract Celebrates 15 Years of Success as Contract Research Organization

Connect

x

Submit RFI / RFP

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Contact Synteract

Tell us how to stay in touch with you:

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

 

x

Download Resource

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required

x

To complete your download, please choose an option in the Internet Explorer pop-up window at the bottom of this browser.

x

Opt In

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required